Potential of Beta-Hydroxybutyrate (BHB) in the Management of Type 2 Diabetes and Risk of Ketoacidosis in Diabetic Patients. (2024). Journal of Pharmaceutical and Sciences, 7(4), 562-570. https://doi.org/10.36490/journal-jps.com.v7i4.520